Covista (CVSA) EBITDA (2009 - 2026)

Covista (CVSA) has 18 years of EBITDA data on file, last reported at $91.3 million in Q1 2026.

• EBITDA for Q1 2026 came in at $91.3 million, up 0.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $86.0 million (down 74.18% YoY), and the FY2025 annual result was $62.7 million, down 71.12% from the prior year.
• EBITDA retreated to $91.3 million in Q1 2026 per CVSA's latest filing, from $111.1 million in the prior quarter.
• Over five years, EBITDA peaked at $111.1 million in Q4 2025 and troughed at -$201.9 million in Q2 2025.
• A 5-year average of $39.3 million and a median of $59.4 million in 2023 frame the typical range for EBITDA.
• The sharpest annual moves came in 2022 and 2025: EBITDA soared 207.12% in 2022, then slumped 394.69% in 2025.
• A 5-year view of EBITDA shows it stood at $45.6 million in 2022, then grew by 28.68% to $58.6 million in 2023, then surged by 77.22% to $103.9 million in 2024, then advanced by 6.97% to $111.1 million in 2025, then dropped by 17.79% to $91.3 million in 2026.
• Business Quant data shows CVSA's EBITDA at $91.3 million in Q1 2026, $111.1 million in Q4 2025, and $85.5 million in Q3 2025.